Latest Orion Pharma News & Updates

See the latest news and media coverage for Orion. We track all announcements, press releases, and industry mentions in real time, all in one place.

Orion Pharma (Orion)

Finnish pharmaceutical company

orionpharma.com

Headquarters: Espoo, Finland
Company type: Public company
Number of employees: 3,500–5,000
Industry: Pharmaceuticals

Last updated Today

Latest news about Orion Pharma (Orion)

In short: Orion achieved significant growth in 2026, reporting a 59.6% jump in H1 operating profit and expanding its oncology and animal health portfolios.

Company announcements

July 17 Orion

Orion reports half-year financial results for H1 2026

Net sales rose 21.8% to EUR 939.3 million, operating profit increased 59.6%, and outlook was raised.

July 15 Orion

Orion converts 45,611 A shares into B shares

The conversion, entered into the Trade Register on 15 July 2026, adjusts the share structure and total votes.

June 23 Orion

Orion's ODM-212 granted orphan designation for malignant mesothelioma

The European Commission granted the designation based on EMA recommendation, following FDA's prior orphan drug designation.

June 10 Orion

Orion commits to 70% emissions reduction by 2030.

The target covers Scopes 1&2 and relies on energy efficiency, electrification, and carbon-free sources.

Media coverage

July 6 AFP

Orion and Shilpa Medicare Expand Partnership to Develop and Supply Nivolumab Biosimilar for Europe

Shilpa Medicare Limited announced that its wholly owned subsidiary, Shilpa Biologicals Private Limited, has entered into a co-development and supply agreement with Orion Corporation for...

July 3 Yahoo Finance

Orion publishes Half-Year Report for January–June 2026 and holds a webcast on 17 July 2026

ORION CORPORATION PRESS RELEASE 3 JULY 2026 at 9.00 EEST Orion publishes Half-Year Report for January–June 2026 and holds a ...

June 23 Yahoo Finance

Orion Pharma's ODM-212 Granted Orphan Designation for the Treatment of Malignant Mesothelioma by the European Commission

Orion Corporation (Orion Pharma) today announced that its investigational drug ODM-212 has received Orphan Designation from the European Commission, based on the recommendation from the...

June 16 GlobeNewswire

Orion Oyj: Announcement in accordance with Chapter 9, Section 10 of the Securities Markets Act (BlackRock, Inc.)

Orion Pharma is a Finnish pharmaceutical company – a builder of well-being that operates globally. We develop, manufacture and market human and veterinary pharmaceuticals and active pharmaceutical ingredients. Our operations combine a solid...

Never miss news about Orion

Track Orion and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Orion competitors & trending companies

Browse news for competitors to Orion and other trending companies.